Cargando…
Can glucose‐lowering medications improve outcomes in non‐diabetic heart failure patients? A Bayesian network meta‐analysis
AIMS: The cardioprotective effects of glucose‐lowering medications in diabetic patients with heart failure (HF) are well known. Several large randomized controlled trials (RCTs) have recently suggested that the cardioprotective effects of glucose‐lowering medications extend to HF patients regardless...
Autores principales: | Yeong, Trevor, Mai, Aaron Shengting, Lim, Oliver Z.H., Ng, Cheng Han, Chin, Yip Han, Tay, Phoebe, Lin, Chaoxing, Muthiah, Mark, Khoo, Chin Meng, Dalakoti, Mayank, Loh, Poay‐Huan, Chan, Mark, Yeo, Tiong‐Cheng, Foo, Roger, Wong, Raymond, Chew, Nicholas W.S., Lin, Weiqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934935/ https://www.ncbi.nlm.nih.gov/pubmed/35092176 http://dx.doi.org/10.1002/ehf2.13822 |
Ejemplares similares
-
General Public’s knowledge, awareness, and perception of Cardiometabolic diseases: data from a Singapore study population
por: Anand, Vickram Vijay, et al.
Publicado: (2023) -
The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
por: Chew, Nicholas W.S., et al.
Publicado: (2022) -
Prognostic Outcomes in Acute Myocardial Infarction Patients Without Standard Modifiable Risk Factors: A Multiethnic Study of 8,680 Asian Patients
por: Kong, Gwyneth, et al.
Publicado: (2022) -
Healthier SG – throwing down the gauntlet for specialists to integrate
por: Dalakoti, Mayank, et al.
Publicado: (2023) -
The Association of Plant-Based Diet With Cardiovascular Disease and Mortality: A Meta-Analysis and Systematic Review of Prospect Cohort Studies
por: Quek, Jingxuan, et al.
Publicado: (2021)